Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability and Effects on the Microbiome of Neonatal Administration of Lactiplantibacillus Plantarum ATCC 202195 With or Without Fructooligosaccharide for One or Seven Days: a Phase II Randomized Placebo-controlled Trial in Dhaka, Bangladesh

NCT05180201 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT05180201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05180201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability and Effects on the Microbiome of Neonatal Administration of Lactiplantibacillus Plantarum ATCC 202195 With or Without Fructooligosaccharide for One or Seven Days: a Phase II Randomized Placebo-controlled Trial in Dhaka, Bangladesh
Lead sponsor
The Hospital for Sick Children
Phase
Phase 2
Overall status
Completed
Start date
January 7, 2022
Completion date
November 10, 2022
Enrollment
519 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

infant all, microbial colonization, safety issues, tolerance